Mark Heinen - Sep 12, 2022 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Head of Finance and Interim Chief Financial Officer
Signature
/s/ Mark Heinen
Stock symbol
BTTX
Transactions as of
Sep 12, 2022
Transactions value $
$97,000
Form type
4
Date filed
9/14/2022, 04:37 PM
Previous filing
Jun 28, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $46.3K +23.9K +119.34% $1.94 43.9K Sep 12, 2022 Direct
transaction BTTX Common Stock Purchase $50.7K +26.1K +59.57% $1.94 70K Sep 13, 2022 Direct
holding BTTX Common Stock 2.28K Sep 12, 2022 By daughter
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Head of Finance and Interim Chief Financial Officer